PTC Therapeutics Inc. (PTCT)

NASDAQ: PTCT · Real-Time Price · USD

49.88

0.36 (0.73%)

At close: May 02, 2025, 12:44 PM

PTC Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	806.78M	937.82M	698.8M	538.59M	380.77M	306.98M	264.73M	194.39M	82.7M
Cost of Revenue	57.4M	65.49M	44.68M	32.33M	18.94M	12.13M	12.67M	4.58M	117.63M
Gross Profit	749.38M	872.34M	654.12M	506.26M	361.82M	294.85M	252.06M	189.81M	-34.93M
Operating Income	-302.57M	-349.4M	-439.93M	-374.94M	-397.88M	-192.8M	-115.69M	-64.29M	-132.06M
Interest Income	n/a	n/a	90.87M	86.02M	56.35M	12.49M	n/a	n/a	n/a
Pretax Income	-363.12M	-696.11M	-587.49M	-518.34M	-402.93M	-239.93M	-128.11M	-77.67M	-141.54M
Net Income	-363.3M	-626.6M	-559.02M	-523.9M	-438.16M	-251.58M	-128.08M	-79M	-142.11M
Selling & General & Admin	300.91M	332.54M	326M	285.77M	245.16M	202.54M	153.55M	121.27M	97.13M
Research & Development	534.48M	666.56M	651.5M	540.68M	477.64M	257.45M	171.98M	117.46M	117.63M
Other Expenses	216.56M	n/a	116.55M	54.75M	36.89M	27.65M	129K	-1.28M	-1.21M
Operating Expenses	1.05B	1.31B	1.09B	881.21M	759.7M	487.64M	348.41M	254.11M	214.76M
Interest Expense	166.99M	129.18M	90.87M	86.02M	56.35M	12.49M	12.55M	12.09M	8.28M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.11B	1.29B	1.14B	913.54M	778.64M	499.78M	361.08M	258.68M	214.76M
Income Tax Expense	176K	-69.51M	-28.47M	5.56M	35.23M	11.65M	-29K	1.33M	569K
Shares Outstanding (Basic)	76.85M	74.84M	71.73M	70.47M	66.03M	58.86M	46.58M	39.11M	34.04M
Shares Outstanding (Diluted)	76.85M	74.84M	71.73M	70.47M	66.03M	58.86M	46.58M	39.18M	34.04M
EPS (Basic)	-4.73	-8.37	-7.79	-7.43	-6.64	-4.27	-2.75	-2.02	-4.17
EPS (Diluted)	-4.73	-8.37	-7.79	-7.43	-6.64	-4.27	-2.75	-2.02	-4.17
EBITDA	-120.46M	-330.34M	-367.78M	-374.44M	-297M	-191.38M	-89.47M	-46.61M	-128.77M
EBIT	-196.13M	-566.93M	-496.62M	-432.32M	-346.58M	-227.44M	-115.56M	-64.29M	-132.06M
Depreciation & Amortization	75.66M	236.59M	128.84M	71.52M	49.58M	36.06M	26.09M	17.68M	3.29M